Prelude Therapeutics
PRLD
PRLD
75 hedge funds and large institutions have $438M invested in Prelude Therapeutics in 2021 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 27 increasing their positions, 14 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
2.7% less ownership
Funds ownership: 100.92% → 98.22% (-2.7%)
61% less capital invested
Capital invested by funds: $1.12B → $438M (-$686M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
75
Holding in Top 10
–
Calls
$68K
Puts
$37K
Top Buyers
| 1 | +$5.02M | |
| 2 | +$3.52M | |
| 3 | +$3.34M | |
| 4 |
BlackRock
New York
|
+$2.12M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.62M |
Top Sellers
| 1 | -$13.9M | |
| 2 | -$12.8M | |
| 3 | -$12.5M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$7.99M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$4.55M |